SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEjf Investments Regulatory News (EJFI)

Share Price Information for Ejf Investments (EJFI)

Share Price is delayed by 15 minutes
Get Live Data
130.00    -1.00 (-0.76%)
Bid:
126.00
Ask:
134.00
Spread: 8.00 (6.349%)
Market Cap: £75.51m
EJFI Live PriceLast checked at - London Stock Exchange

Intraday Ejf Investments Share Chart

Buy-back Programme

9 Mar 2020 09:41

RNS Number : 4224F
EJF Investments Ltd
09 March 2020
 

FOR IMMEDIATE RELEASE

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE REPUBLIC OF IRELAND), AUSTRALIA, CANADA, SOUTH AFRICA OR ANY OTHER JURISDICITION WHERE IT IS UNLAWFUL TO DO SO

 

9 March 2020

EJF Investments Ltd

("EJFI" or the "Company")

Buy-back Programme

 

The Directors of EJFI announce that they have approved a share buy-back (the "Buy-back"), under the authorities given at the last annual general meeting held on 21 June 2019 (the "2019 AGM"), of up to £5,000,000 of the Company's ordinary shares (the "Ordinary Shares").

 

At the 2019 AGM, a special resolution was passed granting the Company authority to make market purchases of up to 10,426,623 Ordinary Shares, representing approximately 14.99 per cent. of the Ordinary Shares in issue as at 14 May 2019 (being the last practicable date before publication of the notice of the 2019 AGM), such authority to expire at the conclusion of the 2020 annual general meeting or, if earlier, 31 July 2020.

 

The Directors have determined that the Company has excess cash reserves and will therefore deploy up to £5,000,000 by means of a share buy-back, on an ad hoc basis with a view, inter alia, to addressing any imbalance between the supply of, and demand for, the Ordinary Shares, to increase the NAV per Ordinary Share and to assist in minimising any discount to the NAV per Ordinary Share at which Ordinary Shares may be trading.

 

Investors should note that the purchase of Ordinary Shares by the Company is entirely discretionary, and no expectation or reliance should be placed on the Directors exercising such discretion on any one or more occasions.

 

The Buy-back will commence today, 9 March 2020, and will continue until further notice. Numis Securities Limited will be instructed to execute the trades on behalf of the Company.

 

Listing Rule 12.4.1R (which the Company voluntarily complies with) and the provisions of the Market Abuse Regulation (Regulation (EU) No. 596/2014) and will be discontinued in the event that the Company ceases to have the necessary general authority to purchase Ordinary Shares.

 

ENQUIRIES

 

For the Investment Manager

EJF Investments Manager LLC

Peter Stage / Hammad Khan / Matthew Gill

pstage@ejfcap.com / hkhan@ejfcap.com / mgill@ejfcap.com

+44 203 752 6775 / +44 203 752 6771 / +44 203 752 6774

 

For the Company Secretary and Administrator

BNP Paribas Securities Services S.C.A

jersey.bp2s.ejf.cosec@bnpparibas.com

+44 1534 709 181 / +44 1534 813 996

 

For the Broker

Numis Securities Limited

David Luck

d.luck@numis.com

+44 20 7260 1301

About EJF Investments Ltd

EJFI is a registered closed-ended limited liability company incorporated in Jersey under the Companies (Jersey) Law 1991, as amended, on 20 October 2016 with registered number 122353. The Company is regulated by the Jersey Financial Services Commission (the "JFSC"). The JFSC is protected by both the Collective Investment Funds (Jersey) Law 1988 and the Financial Services (Jersey) Law 1998, as amended, against liability arising from the discharge of its functions under such laws.

The JFSC has not reviewed or approved this announcement.

LEI: 549300XZYEQCLA1ZAT25

Investor information & warnings

The latest available information on the Company can be accessed via its website at www.ejfi.com.

 

This communication has been issued by, and is the sole responsibility of, the Company and is for information purposes only. It is not, and is not intended to be an invitation, inducement, offer or solicitation to deal in the shares of the Company. The price and value of shares in the Company and the income from them may go down as well as up and investors may not get back the full amount invested on disposal of shares in the Company. An investment in the Company should be considered only as part of a balanced portfolio of which it should not form a disproportionate part. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSUPUBWWUPUUBB
Date   Source Headline
28th Mar 20247:00 amRNSAnnual Financial Report to 31 December 2023
21st Mar 20247:00 amRNSNet Asset Value and Portfolio Update
15th Mar 202410:40 amRNSResults Presentation for the YE 31 December 2023
21st Feb 20247:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
31st Jan 20243:00 pmRNSQUARTERLY REPORT
29th Jan 20244:57 pmRNSDividend Declaration - Replacement
29th Jan 20247:00 amRNSDividend Declaration
22nd Jan 20247:00 amRNSNet Asset Value and Portfolio Update
22nd Dec 20237:00 amRNSCorporate Update
20th Dec 20237:00 amRNSNet Asset Value and Portfolio Update
21st Nov 20237:00 amRNSNet Asset Value and Portfolio Update
2nd Nov 202310:43 amRNSQUARTERLY REPORT
25th Oct 20237:00 amRNSDividend Declaration
20th Oct 20237:00 amRNSNet Asset Value(s)
21st Sep 20237:00 amRNSNet Asset Value and Portfolio Update
8th Sep 20237:00 amRNSHalf-year Report
25th Aug 20234:32 pmRNSUpdate to composition of the Board of Directors
23rd Aug 20232:42 pmRNSNotice of Interim Results and Results Presentation
21st Aug 20237:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
1st Aug 20237:00 amRNSQUARTERLY REPORT
27th Jul 20235:34 pmRNSDividend Declaration
27th Jul 20237:00 amRNSPortfolio Update
20th Jul 20237:00 amRNSNet Asset Value and Portfolio Update
21st Jun 20237:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
21st Jun 20237:00 amRNSCORPORATE UPDATE
13th Jun 20234:07 pmRNSResult of AGM
25th May 20239:14 amRNSQuarterly Report
24th May 20237:00 amRNSNet Asset Value and Portfolio Update
18th May 20235:22 pmRNSNotice of AGM
26th Apr 20233:13 pmRNSDividend Declaration
25th Apr 20235:12 pmRNSDividend Declaration
25th Apr 20237:00 amRNSNet Asset Value(s)
5th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
31st Mar 20237:00 amRNSAnnual Financial Report to 31 December 2022
29th Mar 20237:00 amRNSPortfolio Update
21st Mar 20237:00 amRNSNet Asset Value(s)
15th Mar 20237:00 amRNSPortfolio Update
27th Feb 20237:00 amRNSResults of Placing
21st Feb 20237:00 amRNSNet Asset Value(s)
20th Feb 20237:00 amRNSIssue of 2025 ZDP Shares under Placing Programme
26th Jan 20235:07 pmRNSDividend Declaration
23rd Jan 20237:00 amRNSNet Asset Value(s)
11th Jan 20232:10 pmRNSCorporate Update
21st Dec 20227:00 amRNSNet Asset Value(s)
21st Nov 20227:00 amRNSNet Asset Value(s)
16th Nov 20224:21 pmRNSDirector/PDMR Shareholding
1st Nov 20227:00 amRNSRedemption of 2022 ZDP Shares
27th Oct 20224:57 pmRNSDividend Declaration
21st Oct 20227:00 amRNSNet Asset Value and Corporate Update
22nd Sep 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.